WeVote
Log In

Bill

Bill

HB 557

Central Bank Digital Currency; prohibit governmental entities from using.

2025 Regular Session

Transfers regulation of utilization review to the Insurance Department, adds strict timelines, transparency, and a private right of action to ensure faster, accountable insurer dec

Died In Committee
#bankingandfinancialservices
0
WeVote Research Nonpartisan
Bill Summary · HB 557

Note: the document you provided contains mixed material from multiple bills and states. You listed HB 557 as a CBDC (central bank digital currency) prohibition bill, but the primary bill text included in the file is an Alabama bill titled the "Health Care Service Utilization Review, Accountability, and Transparency Act" (amending Sections 27‑3A‑1 through 27‑3A‑6 and adding 27‑3A‑7). Below I summarize the Alabama utilization‑review bill contained in the document. If you instead want a summary of the CBDC prohibition bill (or another bill referenced), tell me which and I will prepare that summary.

Summary — HB 557 (Alabama): Health Care Service Utilization Review, Accountability, and Transparency Act

Purpose and intent

The bill would (1) move enforcement and oversight of utilization review (the prior‑authorization and coverage‑determination process used by health insurers) from the Alabama Department of Public Health to the Alabama Department of Insurance, and (2) strengthen transparency, timeliness, accountability, and consumer protections in insurer utilization‑review practices.

Key provisions and changes

  • Renames/frames the statute as the "Health Care Service Utilization Review, Accountability, and Transparency Act" and amends Sections 27‑3A‑1 through 27‑3A‑6; adds Section 27‑3A‑7.
  • Agency oversight: Transfers regulatory and enforcement authority for utilization review to the Alabama Department of Insurance (Commissioner defined as the Insurance Commissioner).
  • Time limits for decisions:
    • Non‑urgent care prior‑authorization/coverage determinations must be made and communicated to a provider within 72 hours.
    • Urgent care requests must be decided and communicated within 24 hours.
  • Clinical review requirement: Coverage determinations must be reviewed by a licensed health‑care professional.
  • Reporting and transparency:
    • Insurers must annually report to the Department of Insurance the number of coverage requests denied.
    • Insurers must make their coverage criteria, policies and guidelines accessible to enrollees and health‑care providers.
  • Ombudsman: Requires the Department of Insurance to establish an ombudsman program to receive and investigate complaints from enrollees and providers about utilization decisions.
  • Definitions: Expands the statute’s definitions (e.g., “urgent care request,” “artificial intelligence,” “coverage determination,” “policies and guidelines,” etc.) to clarify scope and processes.
  • Enforcement and remedies:
    • Grants the Department of Insurance civil enforcement powers, including authority to impose fines on insurers who violate the Act.
    • Recognizes a private right of action—an enrollee aggrieved by a utilization‑review determination may pursue civil damages.

Who would be affected

  • Insurers and third‑party utilization review agents doing business in Alabama: new procedural, reporting, transparency, and timeline requirements; potential fines and litigation exposure.
  • Health‑care providers: faster notifications, access to insurer criteria, and an additional route (ombudsman) to contest denials.
  • Enrollees/consumers: increased transparency, quicker decisions for urgent and nonurgent requests, and an explicit private right to sue for damages caused by wrongful denials or delays.
  • Alabama Department of Insurance: would assume regulatory, investigative, and enforcement responsibilities previously under Public Health.

Enforcement, timelines, and status

  • The bill sets explicit maximum timeframes for decisions (24/72 hours) and requires annual denial reporting.
  • It authorizes civil fines by the Department of Insurance and preserves private civil litigation as a remedy for harmed enrollees.
  • As provided in your metadata, the bill’s status is listed as “Died In Committee.” (Note: the document also includes internal filing/reading dates in April 2025; verify current status with the official legislative site if you need up‑to‑date action history.)

Potential impacts and considerations

  • Likely faster prior‑authorization decisions should reduce delays in care but will increase insurer operational demands to meet timeframes and reporting.
  • Shifting oversight to the Department of Insurance could change enforcement focus and resources compared with Public Health oversight.
  • The private cause of action increases potential litigation and liability costs for insurers; penalties and administrative enforcement could incentivize compliance.
  • Requiring licensed clinician review and public access to criteria enhances transparency, but the bill’s effectiveness will depend on rulemaking and resourcing (e.g., staffing the ombudsman office).

If you want: I can (a) produce a one‑page fact sheet for insurers/providers, (b) extract exact statutory text changes (sections/line numbers), or (c) instead summarize the CBDC prohibition bill you referenced. Which would you prefer?

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.